9:15AM – 12:15PM
WORKSHOP:HOW TO GUIDE YOUR ORGANIZATION THROUGH AN RX-TO-OTC SWITCH
Susan B. Levy, Founder and Principal, SUSAN B. LEVY CONSULTING
Switching a drug from prescription to OTC status is an expensive, time-consuming NDA-driven process. With rarely more than one switch approved each year in the United States, each switch program is unique, and not all are successful. Nonetheless, Rx-to-OTC switch remains a very effective mechanism for launching new and differentiated consumer brands. This workshop is designed to provide an overview of the switch process to optimize the required clinical, regulatory and marketing investment.
- Firm up the “basics” of the switch process
- Update best practices for building a successful Rx-to-OTC switch program
- Select the ideal Rx-to-OTC switch candidates
*There will be a half-hour networking break at 10:30.